Artiva Biotherapeutics, Inc. ARTV Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s operating income?
- Artiva Biotherapeutics, Inc. (ARTV) reported operating income of -$24.43M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s operating income changed year-over-year?
- Artiva Biotherapeutics, Inc.'s operating income decreased by 10.2% year-over-year, from -$22.17M to -$24.43M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s operating income?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s operating income has grown at a 71.1% compound annual growth rate (CAGR), from -$30.67M to -$89.81M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.